高级检索
    胡明涛, 李宇红, 黎莹. 三药方案成为胰腺癌术后辅助化疗的首选[J]. 循证医学, 2019, 19(5): 273-276. DOI: 10.12019/j.issn.1671-5144.2019.05.006
    引用本文: 胡明涛, 李宇红, 黎莹. 三药方案成为胰腺癌术后辅助化疗的首选[J]. 循证医学, 2019, 19(5): 273-276. DOI: 10.12019/j.issn.1671-5144.2019.05.006
    shu
    HU Ming-tao, LI Yu-hong, LI Ying. Triple Regimen Is Preferred in Adjuvant Chemotherapy for Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(5): 273-276. DOI: 10.12019/j.issn.1671-5144.2019.05.006
    Citation: HU Ming-tao, LI Yu-hong, LI Ying. Triple Regimen Is Preferred in Adjuvant Chemotherapy for Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(5): 273-276. DOI: 10.12019/j.issn.1671-5144.2019.05.006
    shu

    三药方案成为胰腺癌术后辅助化疗的首选

    Triple Regimen Is Preferred in Adjuvant Chemotherapy for Pancreatic Cancer

      摘要
      • HTML全文
      • 参考文献(11)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回